Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 12

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 12
---
 on our Board and should be directed to our Corporate Secretary at the address of our principal executive office set forth above. For additional information regarding stockholder recommendations for director candidates, see the section titled “Board of Directors and Corporate Governance — Stockholder Recommendations and Nominations to the Board of Directors” in our proxy statement for the 2025 annual meeting of stockholders, filed with the SEC on May 16, 2025. Our Bylaws also permit stockholders to nominate directors for election at an annual meeting of stockholders. To nominate a director, the stockholder must provide the information required by our Bylaws. In addition, the stockholder must give timely notice to our Corporate Secretary in accordance with our Bylaws, which, in general, require that the notice be received by our Corporate Secretary within the time periods described above under the section titled “Stockholder Proposals” for stockholder proposals that are not intended to be included in a proxy statement. Availability of Bylaws A copy of our Bylaws is available via the SEC’s website at http://www.sec.gov. You may also contact our Corporate Secretary at the address set forth above for a copy of the relevant provisions of our Bylaws regarding the requirements for making stockholder proposals and nominating director candidates. 7

PROPOSAL NO. 1: APPROVAL OF THE REPRICING OF CERTAIN STOCK OPTIONS ISSUED UNDER THE 2022 PLAN We are asking our stockholders to approve the repricing of certain stock options issued under the 2022 Plan that are held by eligible service providers of the Company. The following discussion summarizes certain aspects of the option repricing that is the subject of this Option Repricing Proposal (the “Option Repricing”). Overview On October 27, 2025, the Board approved the Option Repricing upon the determination by the disinterested directors to approve the Option Repricing. Stockholder approval of the Option Repricing is required under Nasdaq Rules and the terms of the 2022 Plan. The Company maintains equity incentive plans for the benefit of directors, employees and certain consultants of the Company. The purpose of the equity incentive plans and the equity awards granted thereunder is to provide an incentive for our employees and directors to focus on driving growth in our stock price and long-term stockholder value creation, and help us to attract and retain key talent in a competitive market. Specifically, the granting of stock options helps ensure that the interests of our employees and directors are aligned with those of our stockholders as the options only have value if the